Treatment begins at 2.5mg weekly for the first four weeks, which is a starter dose designed to help your body adjust to tirzepatide rather than produce significant appetite suppression
Young LA, Buse JB, Weaver MA et al (2017) Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings: a randomized trial
Shortage of diabetes, weight-loss drug Ozempic expected in Canada, says manufacturer THE CURRENT Canadians are taking Ozempic, but stigma around weight stops them talking about it GLP-1 drugs like Wegovy slow the passage of food through the stomach, helping people feel fuller longer
Cordero MD, Moreno-Fernndez AM, deMiguel M, et al
Pearlman, R
Special-order manufacturers Medicines guidance